Metabolic syndrome in hypertensive patients: Correlation between anthropometric data and laboratory findings

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1624-1626

  Bulhões Mendonça, Kelminda Maria ^a,b   Araújo, Leila ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Edifício Cidade de Manaus 66 ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIC ACID DERIVATIVE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; OUTPATIENT; RISK FACTOR; SEX; TURBIDIMETRY; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY SIZE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 34249880787     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2236     Document Type: Article

References (13)

1. Mansur AP, Souza MFM, Timerman A, Ramires JAF: Tendência do risco de morte por doenças circulatórias, cerebrovasculares e isquêmicas do coração em 11 capitais do Brasil, de 1980 a 1998. Ar Qbras Cardiol 79:269-276, 2002 (in Portuguese)
2. Reaven GM, Hoffman BB: A role for insulin in the aetiology and course of hypertension? Lancet 2:435-437, 1987
3. Grant RW, Meigs JB: Should the insulin resistance syndrome be treated in the elderly? Drugs Aging 21:141-151, 2004
4. Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30:8-13, 2007
5. Mion D, Machado CA, Gomes MAM, Nobre F, Kohlmann O, Amodeo C, Praxedes JN, Pascoal I, Magalhães L: IV Diretrizes Brasileiras de Hipertensão Arterial. Ar Qbras Cardiol 82 (suplemento IV):1-14, 2004 (in Portuguese)
6. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
7. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group: The metabolic syndrome: a new worldwide definition. Lancet 366:1059-1062, 2005
8. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
9. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna R, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649, 1998
10. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA: Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 245:163-174, 1999
11. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845-1850, 2002
12. Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG: Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 29: 26-31,2006
13. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003